NCT04659564View on ClinicalTrials.gov

Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled Study

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 5, 2020

Primary Completion Date

May 28, 2021

Study Completion Date

May 28, 2021

Conditions
Breast Cancer Related LymphedemaLymphedema of Upper ArmLymphedemaQuality of Life
Interventions
DEVICE

User of Dayspring device

The Dayspring™ device is a novel FDA-cleared wearable solution that is portable and easy-to-use sequential compression system.

Trial Locations (2)

94024

PT works, Los Altos

95037

Ginger-K Lymphedema & Cancer Center, Morgan Hill

Sponsors

Lead Sponsor

Koya Medical, Inc.
All Listed Sponsors
lead

Koya Medical, Inc.

INDUSTRY